Risk-adapted salvage treatment with single or tandem autologous stem-cell transplantation for first relapse/refractory Hodgkin's lymphoma: results of the prospective multicenter H96 trial by the GELA/SFGM study group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples